The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

New England Journal of Medicine

Volumn 315, Issue 6, 1986, Pages 341-347

  Newburger, Jane W ^{a,b,c,d,e,f,g}   Takahashi, Masato ^{a,b,c,d,e,f,g}   Burns, Jane C ^{a,b,c,d,e,f,g}   Beiser, Alexa S ^{a,b,c,d,e,f,g}   Chung, Kyung ja ^{a,b,c,d,e,f,g}   Duffy, C Elise ^{a,b,c,d,e,f,g}   Glode, Mary P ^{a,b,c,d,e,f,g}   Mason, Wilbert H ^{a,b,c,d,e,f,g}   Reddy, Venudhar ^{a,b,c,d,e,f,g}   Sanders, Stephen P ^{a,b,c,d,e,f,g}   Shulman, Stanford T ^{a,b,c,d,e,f,g}   Wiggins, James W ^{a,b,c,d,e,f,g}   Hicks, Raquel V ^{a,b,c,d,e,f,g}   Fulton, David R ^{a,b,c,d,e,f,g}   Lewis, Alan B ^{a,b,c,d,e,f,g}   Leung, Donald Y m ^{a,b,c,d,e,f,g}   Colton, Theodore ^{a,b,c,d,e,f,g}   Rosen, Fred S ^{a,b,c,d,e,f,g}   Melish, Marian E ^{a,b,c,d,e,f,g}  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c RADY CHILDREN'S HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f Children's Medical Center   (United States)

^g BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPHENHYDRAMINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADVERSE DRUG REACTION; CHILD; CHILL; CONGENITAL DISORDER; CONGESTIVE HEART FAILURE; CORONARY ARTERY; CORONARY ARTERY ANOMALY; DIAGNOSIS; DRUG COMPARISON; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG THERAPY; ECHOCARDIOGRAPHY; FEVER; HEART; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHADENOPATHY; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEUTROPENIA; PERIPHERAL VASCULAR SYSTEM; PRIORITY JOURNAL; PRURITUS; RASH; SPLEEN; SPLENOMEGALY; THERAPY;

EID: 0022485186     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198608073150601     Document Type: Article

References (21)

1. Kawasaki T. Acule febrile mucocutaneous lymph node syndrome: clinical observations of 50 cases. Jpn J Allerg 1967; 16: 178–222 (in Japanese).
2. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974; 54: 271–6.
3. D.M., Morens, L.J., Anderson, E.S., Hurwitz, National surveillance of Kawasaki disease, Pediatrics, (1980), 65, 21-25
4. Kato H, Ichinose E, Yoshioka F, et al. Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am J Cardiol 1982; 49: 1758–66.
5. Suzuki A, Kamiya T, Ono Y, Takahashi N, Naito Y, Kou Y. Indication of aortocoronary by-pass for coronary arterial obstruction due to Kawasaki disease. Heart Vessels 1985; 1: 94–100.
6. Kusakawa S. Long-term administrative care of Kawasaki disease. Acta Paediatrica Jpn Overseas Ed 1983; 25: 205–9.
7. Furusho K, Kamiya T, Nakano H, et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984; 2: 1055–8.
8. Capannari TE, Daniels SR, Meyer RA, Schwartz DC, Kaplan S. Sensitivity, specificity and predictive value of two-dimensional echocardiography in detecting coronary artery aneurysms in patients with Kawasaki disease. J Am Coll Cardiol 1986; 7: 355–60.
9. Satomi G, Nakamura K, Narai S, Takao A. Systematic visualization of coronary arteries by two-dimensional echocardiography in children and infants: evaluation in Kawasaki's disease and coronary arteriovenous fistulas. Am Heart J 1984; 107: 497–505.
10. Research Committee on Kawasaki Disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo, Japan: Ministry of Health and Welfare, 1984.
11. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. New York: Von Nostrand Reinhold, 1982.
12. Miettinen OS. Theoretical epidemiology: principles of occurrence research in medicine. New York: John Wiley, 1985.
13. SAS user's guide: statistics. 5th ed. Cary, N.C.: SAS Institute. 1985.
14. Breslow NE, Day NE. Statistical methods in cancer research. Vol. 1. The analysis of case control studies. Lyon, France: International Agency for Research on Cancer, 1980.
15. Research Committee on Kawasaki Disease. Report on research concerning Kawasaki disease. Tokyo, Japan: Ministry of Health and Welfare, 1984:48–54 (in Japanese).
16. Leung DYM, Burns J, Newburger JW, Rosen FS, Geha RS. Reversal of immunoregulatory abnormalities in Kawasaki syndrome by intravenous gamma globulin. Clin Res 1985; 33: 564A. abstract.
17. Koren G, Rose V, Lavi S, Rowe R. Probable efficacy of high-dose salicylates in reducing coronary involvement in Kawasaki disease. JAMA 1985; 254: 767–9.
18. Kato H, Koike S. Yokoyama T. Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics 1979; 63: 175–9.
19. Wells MA, Wittek AE. Epstein JS, et al. Inactivation and partitioning of human T-cell lymphotropic virus, type III. during ethanol fractionation of plasma. Transfusion 1986; 26: 210–3.
20. Safety of therapeutic immune globulin preparations with respect to transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR 1986; 35: 231–3.
21. Zuck TF, Preston MS, Tankersley DL, et al. More on partitioning and inactivation of AIDS virus in immune globulin preparations. N Engl J Med 1986; 314: 1454–5.